Aceruloplasminemia is a systemic degenerative disorder characterized by mutations in the ceruloplasmin gene, the absence of serum ceruloplasmin, and iron accumulation in the brain, liver, and other tissues. Iron is an important catalyst of oxyradical-mediated cellular and tissue injury, and (3-cells in the pancreatic islets are susceptible to the cytotoxic effects of oxidative stress. We report three patients with aceruloplasminemia who have late-onset diabetes mellitus (DM) and impaired glucose tolerance (IGT) as well as neurologic symptoms. Their basal lipid peroxide levels, measured as thiobarbituric acid-reactive products, in plasma samples were three times the values for the controls. This increased susceptibility to lipid peroxidation in patients with aceruloplasminemia suggests that free-radical-mediated tissue injury plays a role in the occurrence ofDMand IGT. (Internal Medicine 35: 641-645, 1996) 
Introduction
Ceruloplasmin is a blue copper oxidase that carries more than 95%of the plasma copper content in vertebrates. It is carried by oc2-glycoprotein which is synthesized mainly in the liver. Hereditary aceruloplasminemia is a newly recognized iron metabolism disorder, originally called familial apoceruloplasmin deficiency , which manifests late-onset blepharospasm and retinal degeneration (1) . Subsequent investigations have found patients with late adult onset of extrapyramidal symptomsand ataxia, retinal degeneration, and diabetes mellitus (DM) (2, 3), with DMbeing the common feature.
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Our patients, who did not sutler from DMand impaired glucose tolerance (IGT) at the time of their original presentation ( 1 ) , have recently also shown such findings. Aceruloplasminemia is characterized by mutations in the ceruloplasmin gene and iron accumulation in the tissues (4-7). Despite elucidation of the molecular basis of aceruloplasminemia, the mechanisms that cause tissue injury and systemic degeneration in this disease are still unknown.Iron is a potent catalyst of biological oxidation, and the hydroxyl radical produced in reactions that involve iron, superoxide anions, and hydrogen peroxide is cytotoxic to the insulin-producing p cells of the pancreas (8).
Ceruloplasmin is the major source of plasma ferroxidase activity and inhibits the auto-oxidation of lipids induced by inorganic iron (9, 10). Wespeculate that increased susceptibility to free-radical-mediated tissue injury owing to abnormal iron storage contributes to the DMand IGT suffered by patients with aceruloplasminemia. We here report three patients with aceruloplasminemia accompanied by late-onset DMand IGT and the results of an examination of lipid peroxidation in samples of their plasma.
Materials and Methods
Informed consent was obtained from each patient or from family members.
Western blotting analysis of serum ceruloplasmin Serum samples (5 jig/well) mixed with SDS sample buffer were electrophoresed on 7.5% SDS gels (SDS-PAGE) that had undergone prior heat treatment; the separated proteins were transferred to nitrocellulose membranesby tank blotting. Ceruloplasmin was detected by immunostaining with the primary antibody of anti-human ceruloplasmin rabbit IgG and with biotin-labelled pig anti-rabbit IgG combined with avidin and biotinylated horseradish peroxidase (Dako Japan, Tokyo) ( 1 1 ).
Lipid peroxidation
Lipid peroxidation in the plasma samples was measured by the thiobarbituric acid (TBA) method to detect individual susceptibility or resistance to peroxidation (12). The control subjects were six healthy men and six healthy womenwith no knowncardiovascular, neurologic, or endocrine disease (mean age: 55±6 years old).
Results

Pa tien ts
A 56-year-old woman (II-5), who was asymptomatic except for retinal degeneration at the original presentation despite undetectable ceruloplasmin (1), has suffered from DMfor the past five years. Insulin therapy was begun at age 53. Recently she has noticed blepharospasm. Except for retinal degeneration, there were no abnormal findings for her general state and her intelligence was normal. A neurological examination showed bilateral blepharospasm, but no other disturbance of the cranial nerves. Deeptendon reflexes were increased in the extremities. There was no sensory disturbance, weakness, limb or truncal ataxia, or tremor. Serum iron levels were decreased even thought serum ferritin, a marker of iron deposits, was increased (Table 1 ) . Serum transferrin and the total iron-binding capacity were within the normalranges. There was no biochemical evidence of hepatic injury; whereas, the liver had low signal intensities on both the Tl and T2 weighted MRimages (Fig. 1) .
The pancreas was slightly atrophic on the CTand MRimages. Iron was distributed in the periportal area and primarily within the hepatocytes in the biopsy samples (Fig. 1) . The hepatic iron concentration was increased to 2.4 mg/gm dry weight (normal, <1. 1 mg/gmdry weight). The insulin response to oral glucose loading was decreased (Table 1) , and islet cell antibodies were negative. Diabetes mellitus caused by decreased insulin secretion was suspected from the following findings: fasting serum C peptide 0.38 ng/ml (normal, 1.0-2.7 ng/ml), urine C peptide 9.2 |ig/day (normal, 35-6 1 |ig/day), and serum immunoreactive insulin at six minutes after a glucagon injection 3.5 |iU/ml (normal, 38. 1-67.5 |uU/ml). MRI studies showed abnormally low intensities in the striatum, thalamus, dentate nucleus, and substantia nigra on both the Tl and T2 weighted images, indicative of markedly elevated iron in the brain (Fig. 2 ). An EEGshowedno marked changes. The older sister (II-3) of the present case, whowas reported previously (1), is currently 61 years old and has had blepharospasm and retinal degeneration for the past 10 years. She gradually has developed extrapyramidal symptoms of grimacing and cogweel rigidity, as well as DM.Her younger brother (II-6), who originally presented with retinal degeneration, has shown impaired glucose tolerance (IGT) for the past two years. Laboratory findings showed that their DMand IGT probably was caused by decreased insulin secretion (Table 1) . A hematologic test showed slight hypochromic anemia in both siblings. Serum transferrin and the total iron-binding capacity were within the normal ranges. In contrast, the serum ferritin levels were increased in both siblings despite their low serum iron. Biochemical findings for their hepatic functions were within the normal range (Table 1) . MRIstudies showed abnormally low intensities in the liver as well as in the brain. Eight relatives of these patients, who are entirely asymptomatic, have serumceruloplasmin concentrations that are about 50%of normal; consistent with an obligate heterozygous state. Serum iron, ferritin, and other hematological and biochemical findings for these eight relatives were within the normalrange. Brain and abdomen MRIalso yielded no abnormal findings. There is no history of consanguinity in four generations of this family.
Western blotting analysis As expected, no serum ceruloplasmin bands were found (Fig. 3) , and the other serum proteins were almost normal in all three patients. The eight relatives, however, showed faint bands as compared with the bands of a normal subject (II-2). 
Lipid peroxidation
The concentration ofTBAproducts (which reflects the level of lipid peroxidation) for the homozygouspatients was three times that for the control subjects. Aninverse relation was found between the ceruloplasmin concentrations and quantitative estimates of the TBA products (r=-0.915: p<0.01) (Fig. 4) .
Discussion
Aceruloplasminemia is a newly recognized iron metabolism disorder caused by mutations in the ceruloplasmin gene located on chromosome 3. Investigations of family pedigrees and genetic analyses suggest that this disease is inherited as an autosomal ressesive trait (4-7). The characteristic clinical features for the present three patients were late-onset DM,extrapyramidal symptoms, and retinal degeneration. Similar symptoms have been reported in two separate kindreds with aceruloplasminemia (2, 3). In those patients, iron deposition in the brain, liver, pancreas, and other visceral organs was detected by MR imaging and pathological examinations (3). Although the pathogenesis of aceruloplasminemia has yet to be determined, ceruloplasmin is believed to have an essential role in iron metabolism because of its ferroxidase activity. Astudy of copper-deficient swine showedthat the copper deficiency resulted in a ceruloplasmin deficiency associated with marked iron storage and that the administration of ceruloplasmin could reverse it (13). The release of iron from the iron-storage compartment to the plasma appears to depend on this enzymatic oxidation ( 1 4). The Fet3 protein which functions as a multicopper oxidase and mediates ferrous iron transport on the external surface of the yeast cell has some structural homology to ceruloplasmin (15). These findings suggest that iron release from the cells may be disturbed in patients with aceruloplasminemia.
Iron is a known potent catalyst of biological oxidation. The hepatic iron concentration in the present patient showed an increase of more than two-fold the control value, but there was no biochemical evidence of hepatic injury. Hepatic fibrosis or cirrhosis occurs only with hepatic iron concentrations above a threshold of approximately 22.3 mg/gm dry weight ( 1 6). p-cells from the pancreases of our patients probably were damaged because of decreased insulin secretion. (3-cells are susceptible to the cytotoxic effects ofoxidative stress. H2O2and superoxide radicals generated in the presence of iron react together initiating lipid peroxidation and cell damage (17). An iron chelator, desferrioxamine, ameliorated the severity offree-radical-mediated (3-cell damage in diabetic mice (18). Ferritin also stimulates peroxidation both directly and by the release of free iron in the presence of an adequate concentration of ascorbate.
Ceruloplasmin may limit ferritin iron bioavailability by reincorporating released iron into ferritin (19). The ferroxidase activity of ceruloplasmin is believed to function as an antioxidant by decreasing the available ferrous iron (9, 10). In our patients, the serum ferritin concentrations were markedly elevated. Lipid peroxidation, as measured by TBAproducts, also was greatly increased. The significant association found between increased TBA production in the plasma and aceruloplasminemia leads support to the speculation that ironmediated lipid peroxidation has a role in the development of DMand IGT. Even if susceptibility to oxidative stress is not the primary cause of tissue damage, it still may be biologically important in causing more damage. Aceruloplasminemia must be considered an important risk factor for late-onset DMand IGT.
